Cargando…

USP21 promotes cell proliferation by maintaining the EZH2 level in diffuse large B‐cell lymphoma

BACKGROUND: Diffuse large B‐cell lymphoma (DLBCL) is the most common category of non‐Hodgkin lymphoma (NHL). However, the underlying molecular mechanism of DLBCL remains unclear. METHODS: Real‐time PCR and Western blot analysis were performed to assess the expression of ubiquitin‐specific peptidase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Huixian, Luo, Xiangrui, Zhou, Peng, He, Na, Zhou, Jun, Liu, Min, Xie, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957995/ https://www.ncbi.nlm.nih.gov/pubmed/33389794 http://dx.doi.org/10.1002/jcla.23693

Ejemplares similares

USP21 promotes cell proliferation and metastasis through suppressing EZH2 ubiquitination in bladder carcinoma
por: Chen, Yong, et al.
Publicado: (2017)

miR-10a inhibits cell proliferation and promotes cell apoptosis by targeting BCL6 in diffuse large B-cell lymphoma
por: Fan, Qian, et al.
Publicado: (2016)

The deubiquitinase USP21 maintains the stemness of mouse embryonic stem cells via stabilization of Nanog
por: Jin, Jiali, et al.
Publicado: (2016)

IL-21 Stimulates the expression and activation of cell cycle regulators and promotes cell proliferation in EBV-positive diffuse large B cell lymphoma
por: Wang, Yuxuan, et al.
Publicado: (2020)

USP7 deubiquitinates and stabilizes EZH2 in prostate cancer cells
por: Lee, Jae Eun, et al.
Publicado: (2020)

Immunohistochemical and genomic profiles of diffuse large B-cell lymphomas: Implications for targeted EZH2 inhibitor therapy?
por: Dubois, Sydney, et al.
Publicado: (2015)

USP44 Promotes the Tumorigenesis of Prostate Cancer Cells through EZH2 Protein Stabilization
por: Park, Jae Min, et al.
Publicado: (2019)

Derepressing of STAT3 and USP7 contributes to resistance of DLBCL to EZH2 inhibition
por: He, Chenyun, et al.
Publicado: (2023)

Prognostic Value of Histone Modifying Enzyme EZH2 in RCHOP-Treated Diffuse Large B-Cell Lymphoma and High Grade B-Cell Lymphoma
por: Petronilho, Sara, et al.
Publicado: (2021)

Downregulation of USP18 reduces tumor-infiltrating activated dendritic cells in extranodal diffuse large B cell lymphoma patients
por: Zhao, Chong, et al.
Publicado: (2021)

Somatic mutation of EZH2 (Y641) in Follicular and Diffuse Large B-cell Lymphomas of Germinal Center Origin
por: Morin, Ryan D., et al.
Publicado: (2010)

Unmasking the suppressed immunopeptidome of EZH2-mutated diffuse large B-cell lymphomas through combination drug treatment
por: Bourne, Christopher M., et al.
Publicado: (2022)

Primary breast diffuse large B-cell lymphoma in the era of rituximab
por: Zhang, Na, et al.
Publicado: (2016)

NIPP1 maintains EZH2 phosphorylation and promoter occupancy at proliferation-related target genes
por: Minnebo, Nikki, et al.
Publicado: (2013)

HDAC1,2 inhibition impairs EZH2- and BBAP- mediated DNA repair to overcome chemoresistance in EZH2 gain-of-function mutant diffuse large B-cell lymphoma
por: Johnson, Danielle P., et al.
Publicado: (2014)

NEK2 Promotes Cell Proliferation and Glycolysis by Regulating PKM2 Abundance via Phosphorylation in Diffuse Large B-Cell Lymphoma
por: Zhou, Lingna, et al.
Publicado: (2021)

The novel LSD1 inhibitor ZY0511 suppresses diffuse large B-cell lymphoma proliferation by inducing apoptosis and autophagy
por: Liu, Huan, et al.
Publicado: (2021)

Artemether suppresses cell proliferation and induces apoptosis in diffuse large B cell lymphoma cells
por: Zhao, Xinying, et al.
Publicado: (2017)

Combination Treatment with GSK126 and Pomalidomide Induces B-Cell Differentiation in EZH2 Gain-of-Function Mutant Diffuse Large B-Cell Lymphoma
por: Park, Sungryul, et al.
Publicado: (2020)

Curcumin Inhibits the Proliferation, Migration, Invasion, and Apoptosis of Diffuse Large B-Cell Lymphoma Cell Line by Regulating MiR-21/VHL Axis
por: Chen, Ling, et al.
Publicado: (2020)

ERK-mediated Cytoplasmic Retention of USP11 Contributes to Breast Cancer Cell Proliferation by Stabilizing Cytoplasmic p21
por: Li, Ling, et al.
Publicado: (2022)

Rituximab maintenance therapy for patients with diffuse large B-cell lymphoma: A meta-analysis
por: Zhou, Xuan, et al.
Publicado: (2017)

EZH2 regulates neuroepithelium structure and neuroblast proliferation by repressing p21
por: Akizu, Naiara, et al.
Publicado: (2016)

Divergent Effects of EZH1 and EZH2 Protein Expression on the Prognosis of Patients with T-Cell Lymphomas
por: Schümann, Franziska Lea, et al.
Publicado: (2021)

Ezh1 Targets Bivalent Genes to Maintain Self-Renewing Stem Cells in Ezh2-Insufficient Myelodysplastic Syndrome
por: Aoyama, Kazumasa, et al.
Publicado: (2018)

EZH2 K63-polyubiquitination affecting migration in extranodal natural killer/T-cell lymphoma
por: Li, Boheng, et al.
Publicado: (2023)

Effect of interleukin 21 and its receptor on CD8(+) T cells in the pathogenesis of diffuse large B-cell lymphoma
por: CHA, ZHANSHAN, et al.
Publicado: (2014)

EZH2/Bcl-2 Coexpression Predicts Worse Survival in Diffuse Large B-cell Lymphomas and Demonstrates Poor Efficacy to Rituximab in Localized Lesions
por: Deng, Yujie, et al.
Publicado: (2019)

MicroRNA-155 Downregulation Promotes Cell Cycle Arrest and Apoptosis in Diffuse Large B-Cell Lymphoma
por: Zhu, Fu-qiang, et al.
Publicado: (2016)

USP21 deubiquitinase promotes pancreas cancer cell stemness via Wnt pathway activation
por: Hou, Pingping, et al.
Publicado: (2019)

Metadherin Contributes to the Pathogenesis of Diffuse Large B-cell Lymphoma
por: Ge, Xueling, et al.
Publicado: (2012)

Effects of microRNA-21 on apoptosis by regulating the expression of PTEN in diffuse large B-cell lymphoma
por: Song, Jia, et al.
Publicado: (2017)

Tenovin-6 inhibits proliferation and survival of diffuse large B-cell lymphoma cells by blocking autophagy
por: Yuan, Hongfeng, et al.
Publicado: (2017)

Ras interacting protein 1 facilitated proliferation and invasion of diffuse large B-cell lymphoma cells
por: Xing, Xiaojing, et al.
Publicado: (2023)

Preliminary study on decreasing the expression of FOXP3 with miR-155 to inhibit diffuse large B-cell lymphoma
por: Zhang, Jincheng, et al.
Publicado: (2017)

USP9X destabilizes pVHL and promotes cell proliferation
por: Zhang, Cong, et al.
Publicado: (2016)

USP1 Maintains the Survival of Liver Circulating Tumor Cells by Deubiquitinating and Stabilizing TBLR1
por: Li, Yuancheng, et al.
Publicado: (2020)

USP14 promotes the malignant progression and ibrutinib resistance of mantle cell lymphoma by stabilizing XPO1
por: Zhang, Ye, et al.
Publicado: (2023)

EZH2 inhibitors abrogate upregulation of trimethylation of H3K27 by CDK9 inhibitors and potentiate its activity against diffuse large B-cell lymphoma
por: Xie, Shao, et al.
Publicado: (2020)

The regulation of NONO by USP11 via deubiquitination is linked to the proliferation of melanoma cells
por: Feng, Peifu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jgngeo048c903b60h47oku768g